ESTIARTE-MARTINEZ; Maria de los Angeles

Patent Applications and Registrations

Patent applications and USPTO patent grants for ESTIARTE-MARTINEZ; Maria de los Angeles.The latest application filed is for "thrombin inhibitors, formulations, and uses thereof".

Company Profile

4.6.13

ESTIARTE-MARTINEZ; Maria de los Angeles - Fremont CA
Estiarte Martinez; Maria de los Angeles - San Francisco CA
Estiarte-Martinez; Maria de los Angeles - Barcelona ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thrombin Inhibitors, Formulations, And Uses Thereof App 20210315877 - SHORT; Kevin Michael ; et al.	2021-10-14
Substituted Pyrazole Compounds As Serine Protease Inhibitors App 20200109132 - SHORT; Kevin Michael ; et al.	2020-04-09
Substituted pyrazole compounds as serine protease inhibitors Grant 10,532,995 - Short , et al. Ja	2020-01-14
Pyrazolyl-substituted Pyridone Compounds As Serine Protease Inhibitors App 20190359586 - Short; Kevin Michael ; et al.	2019-11-28
Pyrazolyl-substituted pyridone compounds as serine protease inhibitors Grant 10,189,810 - Short , et al. Ja	2019-01-29
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180354902 - Ortega Munoz; Alberto ; et al.	2018-12-13
Substituted Pyrazole Compounds As Serine Protease Inhibitors App 20180237421 - SHORT; Kevin Michael ; et al.	2018-08-23
Pyrazolyl-substituted Pyridone Compounds As Serine Protease Inhibitors App 20170267656 - SHORT; Kevin Michael ; et al.	2017-09-21
Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,676,701 - Fyfe , et al. June 13, 2	2017-06-13
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,487,512 - Ortega Munoz , et al. November 8, 2	2016-11-08
Cyclopropylamine Derivatives Useful As Lsd1 Inhibitors App 20160052865 - FYFE; Matthew Colin Thor ; et al.	2016-02-25
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150119396 - Ortega Munoz; Alberto ; et al.	2015-04-30
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20130045973 - Duncton; Matthew ; et al.	2013-02-21
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Grant 8,163,901 - Duncton , et al. April 24, 2	2012-04-24
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20120088746 - Shishido; Yuji ; et al.	2012-04-12
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Grant 8,153,651 - Cox , et al. April 10, 2	2012-04-10
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20110028465 - Duncton; Matthew ; et al.	2011-02-03
Amide Derivatives As Ion-channel Ligands And Pharmaceutical Compositions And Methods Of Using The Same App 20110021514 - Cox; Matthew ; et al.	2011-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.